Variant report
Variant | esv2528133 |
---|---|
Chromosome Location | chr8:52585076-52586328 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555154990 | chr8:52585083-52585084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538257432 | chr8:52585096-52585097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35775972 | chr8:52585117-52585118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540886546 | chr8:52585129-52585130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565467117 | chr8:52585136-52585137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7007741 | chr8:52585139-52585140 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs544320571 | chr8:52585189-52585190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs80252470 | chr8:52585194-52585195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6988401 | chr8:52585295-52585296 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs546941853 | chr8:52585365-52585366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144984638 | chr8:52585412-52585413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147170046 | chr8:52585430-52585431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552427818 | chr8:52585460-52585461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11987250 | chr8:52585513-52585514 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs75488701 | chr8:52585578-52585579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549471727 | chr8:52585580-52585581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568066510 | chr8:52585621-52585622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535515156 | chr8:52585657-52585658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370729331 | chr8:52585660-52585661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139499717 | chr8:52585683-52585684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573452518 | chr8:52585734-52585735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186945385 | chr8:52585755-52585756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565333730 | chr8:52585795-52585796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11990577 | chr8:52585796-52585797 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs55927765 | chr8:52585808-52585809 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs533340175 | chr8:52585848-52585849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7845169 | chr8:52585862-52585863 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs574505130 | chr8:52585881-52585882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541902240 | chr8:52585991-52585992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149725790 | chr8:52586039-52586040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527480760 | chr8:52586050-52586051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192088505 | chr8:52586078-52586079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145555681 | chr8:52586111-52586112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183317309 | chr8:52586137-52586138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76696976 | chr8:52586155-52586156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568026413 | chr8:52586212-52586213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535478664 | chr8:52586223-52586224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547510637 | chr8:52586276-52586277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs41372147 | chr8:52586278-52586279 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs568273786 | chr8:52586326-52586327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52580600-52585400 | Weak transcription | Fetal Lung | lung |
2 | chr8:52580600-52585800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:52580600-52586000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:52580800-52598800 | Weak transcription | Right Atrium | heart |
5 | chr8:52583400-52589000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:52585000-52595000 | Weak transcription | Left Ventricle | heart |
7 | chr8:52585400-52586600 | Enhancers | Fetal Lung | lung |
8 | chr8:52585800-52587800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr8:52586000-52586800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr8:52586000-52587400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |